This design allowed us to rapidly discover and validate eight proteins, namely p53, ETHE1, CTAG1A, C1QTNF1, TEX264, CLDN2, NSG1, and HRas, as biomarkers for LC early diagnosis. This evidence concerns the gene HRAS and laryngotracheoesophageal cleft.